Genetic Signatures (GSS) Short Interest
Genetic Signatures (ASX:GSS) had 0.00% of shares reported as short positions as of 8 June 2026, representing 7,000 shares. Genetic Signatures operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Genetic Signatures
Genetic Signatures is a molecular diagnostics company focused on transforming diagnostics through streamlined sample processing and highly multiplexed real-time PCR screening assays. Their EasyScreen™ Detection Kits aim to simplify and improve the identification of infectious diseases. The company is based in Australia and has a global presence.
Short position
Genetic Signatures (ASX:GSS) has 0.00% of its shares on issue reported as short positions as of 8 June 2026, or about 7,000 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.24% in June 2024. GSS is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 34, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4GSS intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Genetic Signatures
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss GSS
Start a research thread or post the first pulse update